Inhibition of drug binding to serum albumin

Details for Australian Patent Application No. 2004238263 (hide)

Owner Syntonix Pharmaceuticals, Inc.

Inventors Stattel, James M.; Peters, Robert T.; Bitonti, Alan J.; Palombella, Vito J.

Agent Cullen & Co

Pub. Number AU-A-2004238263

PCT Pub. Number WO2004/100882

Priority 60/469,603 06.05.03 US

Filing date 6 May 2004

Wipo publication date 25 November 2004

International Classifications

A61K 031/00

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/100882 Priority application(s): WO2004/100882

7 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238270-Metallic implantable grafts and method of making same

2004238259-System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram